Skip to main navigation
Crescent Biopharma corporate site
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Contact
  • Pipeline
    • Overview
    • CR-001 (PD-1 x VEGF)
    • CR-002 (PD-L1 ADC)
    • CR-003 (ITGB6 ADC)
    • Presentations & Publications
  • Patients
    • Commitment
    • Clinical Trials
    • Expanded Access
    • Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Investor Resources
  • Careers
    • Culture & values
    • Benefits
    • Open Positions

SEC Filing Details

Document Details

Form
EFFECT
Filing Date
Jul 31, 2026
Document Date
Jul 31, 2026
Form Description
EFFECT
Filing Group
Other
Company
Crescent Biopharma
Issuer
CRESCENT BIOPHARMA, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Contact IR Email
300 Fifth Avenue
Waltham, MA 02451
info@crescentbiopharma.com
in x
Crescent Biopharma }}
©2026 All rights reserved.
Privacy policy Terms of service